BIOLOGIC AGENTS IN IBD PATIENTS AFTER SOLID ORGAN TRANSPLANTATION DO NOT INCREASE THE RATES OF INFECTION OR ADVERSE EVENTS

Linda Cingolani  ¹     Greta Lorenzon     Fabiana Zingone     Renata D'Incà     Ilaria Marsilio     Brigida Barberio     Flavio Caprioli  ²     Davide Giuseppe Ribaldone  ³     Antonio Rispo  ⁴     Agnese Miranda  ⁵     Daniela Pugliese  ⁶     Lorenzo Bertani  ⁷     Ambrogio Orlando  ⁸     Andrea Buda  ⁹     Alberto Ferrarese  ¹⁰     ANTONINO CARLO Privitera  ¹¹     Martina Gambato     Patrizia Burra     Edoardo Vincenzo Savarino    
¹ Padua University Hospital, Padua, Italy
² Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico of Milan, Milan, Italy
³ University of Turin, Turin, Italy
⁴ University ´´Federico II´´of Naples, Naples, Italy
⁵ University of Naples ''Luigi Vanvitelli'', Dragoni ( Caserta), Italy
⁶ Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Rome, Italy
⁷ University of Pisa, Pisa, Italy
⁸ Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello, Palermo, Italy
⁹ Ospedale S. Maria del Prato, Feltre, Italy
¹⁰ Verona University Hospital, Verona, Italy
¹¹ “Cannizzaro" Hospital of Catania, Catania, Italy

Session
Safety and emergencies in lower GI disease (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)